KEY TAKEAWAYS The retrospective study aimed to test the efficacy and tolerability of Atezolizumab + Bevacizumab in pts with HCC. The combination Atezolizumab + Bevacizumab was well-tolerable and effective in HCC. One of the most common causes of cancer-related death...